Evidence map›Paper›PMID 27536877›Full record

ArticleeLife2016

A hyperspectral method to assay the microphysiological fates of nanomaterials in histological samples.

Elliott D SoRelle, Orly Liba, Jos L Campbell, Roopa Dalal, Cristina L Zavaleta, Adam de la Zerda

Abstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elliott D SoRelleMolecular Imaging Program at Stanford, Stanford University, Stanford, United States.ORCID http://orcid.org/0000-0002-3362-1028
Orly LibaMolecular Imaging Program at Stanford, Stanford University, Stanford, United States.ORCID http://orcid.org/0000-0003-4625-9838
Jos L CampbellMolecular Imaging Program at Stanford, Stanford University, Stanford, United States.
Roopa DalalDepartment of Ophthalmology, Stanford University, Stanford, United States.
Cristina L ZavaletaMolecular Imaging Program at Stanford, Stanford University, Stanford, United States.
Adam de la ZerdaMolecular Imaging Program at Stanford, Stanford University, Stanford, United States.

Funding

Pilot ProjectsU54CA151459 · NCI · STANFORD UNIVERSITY · PI GAMBHIR, SANJIV S · 2010 to 2014
$12.6M
Molecular Biophysics Training Program at StanfordT32GM008294 · NIGMS · STANFORD UNIVERSITY · PI HUANG, KERWYN C. · 1989 to 2019
$7.4M
Molecular Imaging of Protein Glycosylation in Living SubjectsDP5OD012179 · OD · STANFORD UNIVERSITY · PI DE LA ZERDA, ADAM · 2012 to 2016
$2.0M
A New Strategy for Cancer Detection using Raman Spectroscopy with NanoparticlesK22CA160834 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZAVALETA, CRISTINA L. · 2014 to 2016
$582k
A New Raman-based Strategy to Identify Tumor Margins and Guide Surgical ResectionR21CA184608 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZAVALETA, CRISTINA L. · 2015 to 2016
$368k
NCI NIH HHS K22 CA160834NCI NIH HHS R21 CA184608NCI NIH HHS U54 CA151459NIGMS NIH HHS T32 GM008294NIH HHS DP5 OD012179
6 · The paper itself

Abstract

Nanoparticles are used extensively as biomedical imaging probes and potential therapeutic agents. As new particles are developed and tested

Indexed as

biodistributionbiomedical Imagingcancer biologyhistologyhuman biologyhyperspectral Imagingmedicinemicroscopymousenanoparticles

Identifiers

PMID27536877
PMCPMC5042654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.